More than 1,000 children have been affected by the prescribing of sodium valproate, an anti-seizure medication that can cause severe birth defects when used during pregnancy. Families impacted by this issue are seeking clarity and accountability through a long-awaited inquiry aimed at investigating the historical prescribing practices surrounding sodium valproate. The Government has initiated a non-statutory inquiry that is anticipated to take between 12 to 18 months to complete, giving hope to those seeking answers regarding the known risks of the medication.
Families affected by sodium valproate use during pregnancy are calling for a long-awaited inquiry to uncover who knew about the drug's risks and when.
Over 1,000 children are reported to be affected by serious birth defects linked to the anti-seizure medication sodium valproate prescribed to pregnant women.
Collection
[
|
...
]